Novel Biomarkers in Alzheimer's Disease

• Eará dahkkit: Villa, Chiara (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Fáttát: Medicine; flotillin; Alzheimer's disease; biomarker; exosomes; beta-amyloid; Tau; aging; biomarkers; cytokines; cognitive decline; metabolomics; neuroinflammation; multivariate analysis; physical performance; person-tailored; PET/CT; (18F)FDG; neuropsychological assessment; APP mutations; APOE alleles; PSEN1; PSEN2; germline mutations; late onset AD; early onset AD; familial AD; genetics of AD; mitochondrial spare respiratory capacity; mitochondrial; membrane potential; glycolytic reserve; semantic memory; phonemic fluency; episodic memory; neuropsychology; neuroimaging; mild cognitive impairment; EEG; TMS; obesity; diabetes; inflammation; Amyloid Beta; mitochondrial dysfunction; nutrition; omega-3 fatty acids; antioxidant; carotenoids; vitamin E; cognition; older adults; ageing; subjective cognitive decline; clock genes; Clock; ApoE; cardiovascular risk factors; Alzheimer disease; semantic priming; amyloid beta; cerebrospinal fluid; amyloid beta peptide; total tau; phosphorylated tau; diagnosis; drug development; clinical trials; diagnostic research; virus; bacteria; dementia; blood; behavioral and psychological symptoms of dementia (BPSD); Alzheimer's disease (AD); neuropsychiatry inventory scale (NPI); endophenotypes; CART analysis; MTHFR; APOE; COMT; genetic variants; early diagnosis; biofluids; amyloid cascade hypothesis; glucose metabolism; adipose tissue dysfunction; energetic metabolism; lysosomes dysfunction; Type-3-Diabetes; neurodegeneration; amyloid; tau; soluble TREM2; NfL; Multiplex; SiMoA; diagnostics; messenger RNA; microRNA; neurotropic microbes; precision medicine; prognostics; synaptic biomarkers; neurofilament light chain; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

Alzheimer's disease (AD) represents the most common form of dementia in the elderly population worldwide. AD is characterized by progressive neurodegeneration that leads to a gradual deterioration of memory and other cognitive functions. Given the global prevalence and impact of AD, there is a...